Associated Papers
Biallelic NLRP7 variants in patients with recurrent hydatidiform mole: A review and expert consensus.
Slim R et al.
Human Mutation, 2022
Genetic screening of Chinese patients with hydatidiform mole by whole-exome sequencing and comprehensive analysis.
Yang J et al.
Journal of Assisted Reproduction and Genetics, 2022
DNA Methylation Dynamics in the Female Germline and Maternal-Effect Mutations That Disrupt Genomic Imprinting.
Anvar Z et al.
Genes, 2021
NLRP7: From inflammasome regulation to human disease.
Carriere J et al.
Immunology, 2021
Abnormal processing of IL-1β in NLRP7-mutated monocytes in hydatidiform mole patients.
Zhang P et al.
Clinical and Experimental Immunology, 2020
NLRP7 and KHDC3L variants in Chinese patients with recurrent hydatidiform moles.
Ji M et al.
Japanese Journal of Clinical Oncology, 2019
Pathogenic variant in NLRP7 (19q13.42) associated with recurrent gestational trophoblastic disease: Data from early embryo development observed during in vitro fertilization.
Sills ES et al.
Clinical and Experimental Reproductive Medicine, 2017
The genetics of recurrent hydatidiform moles in China: correlations between NLRP7 mutations, molar genotypes and reproductive outcomes.
Qian J et al.
Molecular Human Reproduction, 2011
[Family pedigree analysis in family member with history of hydatidiform mole and the NLRP7 gene expression].
Li Y et al.
Zhonghua Fu Chan Ke Za Zhi, 2011
Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region.
Wang CM et al.
Journal of Medical Genetics, 2009
NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation.
Deveault C et al.
Human Molecular Genetics, 2009
Select a paper to view details